Q2 2018 Holdings
Filed 2018-08-01 | 3 holdings | $69.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Revance Therapeutics, Inc.(RVNCEUR) | COM | 761330109 | $42.8K | 1,558,426 | 61.2% |
| Myovant Sciences Ltd. | COM | G637AM102 | $27.2K | 1,188,361 | 38.8% |